Assumed Vaccine Efficacy for Susceptibility (VES) for naïve and previously infected individuals, estimated from the overall efficacy found by the Sanofi-Pasteur phase III vaccine trial.
收藏Figshare2016-09-28 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/Assumed_Vaccine_Efficacy_for_Susceptibility_i_VE_i_sub_i_S_i_sub_for_na_ve_and_previously_infected_individuals_estimated_from_the_overall_efficacy_found_by_the_Sanofi-Pasteur_phase_III_vaccine_trial_/3936408
下载链接
链接失效反馈官方服务：
资源简介：
Efficacies for naïve and previously infected individuals are calculated assuming a population that is 60% antibody positive and that efficacy in seropositive individuals is twice that of seronegatives.
创建时间：
2016-09-28
